Different pregnancy outcomes according to Polycystic Ovary Syndrome diagnostic criteria: a systematic review and meta-analysis of 79 studies
Full text 👇
https://t.co/yFXdpDSGbJ
Discuss with authors 👇
https://t.co/yrMFwXdFTR
Follicular Activation in Previously diagnosed Poor Ovarian Responders (FAPPOR): A randomized controlled trial
Full text 👇
https://t.co/IVp7oVqxa8
Discuss with authors 👇
https://t.co/oySgzKVq6p
The use of artificial intelligence is here to stay. Can machine learning technology help improve quality assessment (QA) in the IVF laboratory and ultimately improve pregnancy rates? Here is a research article that looks at this topic.
https://t.co/K0zRBeCDeu
@SMDS_research@merckgroup@AndrewDrakeley @SRF_Repro Indeed, really interesting discussion! I wouldn’t go as far as saying that we are ready for precision medicine in ART, but I do believe that at the end of this meeting we designed the best roadmap to get the best answers...only time will tell!
@BortolettoMD @rajmathur7@svli@RitaVassena@PirteaP While you may indeed be right, I’m really hoping you’re not…or else this means that, as a society, we still have much to do to allow patients the much needed time in their workday to seek care for such a fundamental issue.
@BortolettoMD @rajmathur7@svli@RitaVassena@PirteaP We noticed a surge as well, but not as pronounced as it seems to have been in the US. Did the pandemic make couples rethink their priorities?
What is the best luteal support for FET? Check the results of the RCT by Devine et al here:https://t.co/0hWoMw2IRF post created by @samueldsribeiro#FET#Progesterone#IVF
🚨Visual Abstract Alert❤️
Pretreatment antimüllerian hormone levels and outcomes of ovarian stimulation with gonadotropins/intrauterine insemination cycles
Full text below 👇🏼
Visual abstract by @samueldsribeiro
https://t.co/K1xA4SKobi
🚨 Visual Abstract Alert 🚨
Dropout rate and cumulative birth outcomes in couples undergoing in vitro fertilization within a funded and actively managed system of care in New Zealand via @FertStert
👇Link here👇
https://t.co/mS2Yromnvg
NEW webinar! Register now for the upcoming webinar taking place on 8 June 17:00 CET "Going through the COVID-19 transition in the IVF lab: how can quality management help?"
Don't wait too long, places are limited!
Register here: https://t.co/Lczyx4B2Xq
#COVID19#SQART#ESHRE
@maclaudiaa@MackensShari@LaurCraciunas The oocyte donor model is great because it minimizes the bias due to embryo quality. Even in its genesis, oocyte donation already tooted PR>50%...an explanatory RCT such as this one would show whether ES is of any benefit or a waste of time, money, effort, pipelles... #ESHREjc
@maclaudiaa@MackensShari@LaurCraciunas An ongoing trial in IVI Valencia is assessing the potential benefit of ES in a group of oocyte recipients...unfortunately, recruitment is still ongoing #ESHREjc
@FAzpiroz_@maclaudiaa I believe it is more a question of changing mentalities "one study at a time" instead of presenting yellow lights. MDs know the negative studies are out there..if they still recommend ES it is because they feel either helpless or unconvinced... #ESHREjc
@FAzpiroz_@maclaudiaa Ambar is not red...moreover, how many of our patients actually even know what HFEA is, let alone these recommendations? In theory, the tool from HFEA was well-intended, but does it really affect the daily practice in the 50% of patients who are deemed as "RIF"? #ESHREjc